Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus
This study has been completed.
Study NCT00102297   Information provided by FibroGen

First Received on January 26, 2005.   Last Updated on December 10, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus
Additional conditions recognized in this trial
Diabetes Mellitus, Type 2
Kidney Diseases
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Urologic Diseases
Interventions listed in this trial
FG-3019
Sponsors listed in this trial
FibroGen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services